Logotype for Allot Ltd

Allot (ALLT) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Allot Ltd

Q4 2024 earnings summary

23 Dec, 2025

Executive summary

  • Achieved strong Q4 and full-year 2024 results, marking a key inflection point in the turnaround with a return to revenue growth and profitability, driven by double-digit SECaaS growth and improved cash flow.

  • SECaaS (Security-as-a-Service) was a major growth driver, with revenues up 49% year-over-year in Q4 and ARR up 43%.

  • Positive cash flow generated for the first time in years, with year-end cash and equivalents at $58.8 million.

  • Secured significant new contracts, including Verizon, Vodafone UK, O2 Czech Republic, and MEO, expanding market reach and recurring revenue potential.

Financial highlights

  • Q4 2024 revenue was $24.9 million, up 2% year-over-year and 7% sequentially; full-year 2024 revenue was $92.2 million, down 1% from 2023.

  • SECaaS revenue in Q4 was $4.8 million, up 49% year-over-year, making up 19% of quarterly revenue; SECaaS ARR at year-end was $18.2 million.

  • Non-GAAP gross margin for Q4 was 69.7%, up from 51.7% last year; full-year gross margin improved to 70.6% from 59.6%.

  • Non-GAAP net income for 2024 was $1.6 million ($0.04/share), a turnaround from a $53.3 million loss in 2023.

  • Operating cash flow was $4.8 million for the year; cash and equivalents at year-end were $58.8 million.

Outlook and guidance

  • Expecting another year of strong double-digit SECaaS revenue and ARR growth in 2025, with improved profitability.

  • Gross margin expected to remain around 70% in the coming year.

  • Smart product line revenue expected to remain stable, with potential upside from pipeline deals.

  • OpEx expected to remain flat with some increase toward year-end as investments in growth continue.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more